Skip to main content
Smart Investors Daily
PL

OTC · PLSH

Panacea Life Sciences Holdings, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.09

Up+$0.01 (+11.93%)

Updated Aug 25, 2026, 7:09 PM

SID Score

4.7/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.38M
P/E ratio
0.65
Dividend yield
0.00%
52-week range
$0.02 – $0.20
Volume
425
Avg. volume
5.43K

Price performance

PLSH price history

1M range · 0 trading sessions · Daily adjusted prices

PLSH does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest PLSH news

The latest Smart Investors Daily articles mentioning PLSH.

PLSH research

Overview

Company profile and research snapshot.

Company profile

PANACEA LIFE SCIENCE HLD

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · May 16, 2024

Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products

GOLDEN, Colo., May 16, 2024 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea Life Sciences,” “PLSH” or the “Company”), a Colorado-based manufacturing, research and product development company in the natural health and wellness industry, announces the execution of a Supply, Licensing and Development Agreement (Agreement) by its subsidiary, Panacea Life Sciences, Inc. with Sky Wellness, LLC for the marketing and sale of Sky Wellness’ current CBD product inventory and the licensing and development of new products under the trademarked family of Sky Wellness brands.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.